BPC-157
Body Protection Compound-157 (BPC-157) is a 15-amino-acid fragment originally isolated from proteins in the human stomach lining. Most evidence comes from animal studies exploring wound healing, tendon repair, and gut health applications.
Research-reported dosing only. Not medical advice. Consult a healthcare provider.
At A Glance
Supports healing by reducing inflammation, improving blood-vessel repair signaling, and protecting the gut lining.
Promotes angiogenesis and tissue remodeling signals, supporting wound/tendon healing processes.
Improves fibroblast activity and collagen organization (proposed), which may aid soft-tissue repair.
Enhances mucosal defense and epithelial repair signaling, supporting ulcer healing and gut barrier recovery.
Modulates inflammatory damage in GI tissue, which may reduce irritation and speed recovery after injury.
Downshifts pro-inflammatory signaling (proposed), which may reduce local inflammation at injury sites.
Interacts with nitric oxide pathways (proposed), which may influence blood flow and healing response.
May modulate pain/injury signaling indirectly via inflammation reduction (proposed)
Read Full BPC-157 Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Injury, Repair & Recovery
Oral vs Injectable Peptides: Bioavailability, Effectiveness, and When Each Makes Sense
Oral peptides face massive bioavailability barriers, but real exceptions exist. We break down the evidence for oral semaglutide, BPC-157, collagen peptides, and emerging delivery tech.
Clinical Trials for Peptide Drugs Are Surging: Why the Pipeline Is Exploding in 2026
Peptide clinical trials have surged dramatically, with over 150 peptides now in active trials and 400+ in preclinical development. Here's why peptides are becoming the dominant drug class and what it means for the future of medicine.
RFK Jr. Says 14 Peptides Are Coming Back: FDA Category 2 Ban Reversal Explained
HHS Secretary RFK Jr. told Joe Rogan that ~14 peptides banned by the FDA in 2023 will return to Category 1, restoring legal compounding access.
GHK-Cu for Skin, Hair, and Anti-Aging: What the Research Shows
GHK-Cu is a naturally occurring copper peptide that declines with age. Research shows it stimulates collagen, promotes wound healing, and may reverse aspects of gene expression associated with aging. Here's what the science says.